London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Have little idea what Clinigen do besides buy and sell drugs around the world. I guess it worked well for Pablo Escobar. Valuation seems reasonable and very popular holding among fund managers. Covid-19 doesn't seem to have hit it at all.
Something will be coming soon like I said J P Morgan only get involved when something big is going to happen
Yeah i cant find any news either.
Nothing easily searchable / RNS/ company website...volume not particularly high.
Maybe something will emerge later today or tomorrow.
Has there been some news?
Romping away this morning..
Also J.P.Morgan Cazenove only get involved if something is going to be happening
I've just done some basic maths. They state in their latest trading update that Q3 YTD organic gross profit growth was 'over 10%'. In the H1 update it was 9% (although we dont know decimal places, let's assume it was exactly 9.0%, or £87.2m... also assuming that both Q3 and Q4 are equally-weighted, and knowing that H2 delivers 56% of yearly profit, then to move the YTD figure from +9.0% organic growth to 'over 10%', then the minimum Q3 profit growth would have to be +12%, which would deliver total Q3 YTD organic gross profit growth of +10.2%. Assuming that this trend continues into Q4, then that would mean full year organic GP growth of +10.7%, above forecast. Of course, that's worst-case scenario and it could actually be higher than that... no wonder a load of directors bought shares!
Agree
But this share will rise a fair bit when the news comes in
Sorry meant Q3!
Probably have to wait until results day for this to rise... either way, good buy for a company who's profit increased during Q1...
Be careful. If you do find out something you must not trade (buy or sell) before it is communicated on an RNS otherwise you and your cousin could be fined or go to jail for insider trading.
I will know more in the next few weeks. What’s happening
It’s good news all round
I would think a Nasdaq share issue next year is one of the more likely outcomes.
The proleukin deal was large and risky, the more recent deal is smaller and 18m out. I am sure the BOD would like to do a larger deal if they can. There must be some drugs falling out of the recent large US mergers that would fit the bill. However I would rather they buy newer better drugs than try to revive those that are end of patent or being superseded by better treatments.
If moving to the main FTSE, Clin would be around 250 and would need to x4 to make the FTSE100. Possible and would open the company to more investors which can only help the share price
Or Ftse 100
But thinks are definitely going to happen
J P Morgan only get involved to make big monies
sold
Or a move to NASDAQ
What do you think a new NOMAD will bring?
Better marketing to new SH
Move to main board from AIM? NASDAQ listing?
Refinancing?
M&A?
J P Morgan - good news coming Clinigen’s way
Looking forward to it :)
Profit takers tomorrow and then up to £8.00 by close of business Friday - or I’ll moon in Marks n Spencer’s front window. fundamentals are sound
I was lucky I bought when the first few days they went on the market @ £1.80 I think and Andrew leaver is my cousin
Also expect more “ethical” investors to take an interest in drug/ healthcare businesses. A pandemic can trigger a significant mind change in us all. Applies also to individuals/funds looking to invest as we come out of this crisis. Soz, I’m rambling - just my thoughts
I put £20k into this Company at £9.60p per share. topped up with another £10k at £4.81. Still nursing a loss but in for the long haul and comfortable with the investment. Biotech research, drug production and supply will be high profile going forward as investors look to move cash into Sectors least likely to be hit hard
Most likely Liberum upgrade forecast to 850p on the back of the press release
Anyone heard what is driving the sp higher today?
Delayed reaction to fridays update? Or something else?